EnteroMedics (ETRM) Reports Q4 Loss of $2.65

EnteroMedics (NASDAQ: ETRM) reported Q4 EPS of ($2.65), versus ($66.70) reported last year. Revenue for the quarter came in at $141 thousand, versus $149 thousand reported last year.

For earnings history and earnings-related data on EnteroMedics (ETRM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• Beike (BEKE) PT Raised to $23 at Morgan Stanley